Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
NCT00183963Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Aug 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in ductal carcinoma in situ (DCIS), sponsored by University of Southern California. Started Aug 2006; status: terminated.
02
Drugs
fulvestrant
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT00183963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183963.